Quantitative and Qualitative CD4 T Cell Immune Responses Related to Adenovirus DNAemia in Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 4, 2011, Pages 476-485

  Guérin El Khourouj, Valérie ^a   Dalle, Jean Hugues ^a   Pédron, Béatrice ^a   Yakouben, Karima ^a   Bensoussan, Danièle ^b   Cordeiro, Débora Jorge ^a   Peltier, Lucas ^a   Ouachée Chardin, Marie ^a   Baruchel, André ^a,c   Sterkers, Ghislaine ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Adenovirus; Children; HSCT; TCD34

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; VIRUS DNA;

ADENOVIRUS; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNE RESPONSE; INCIDENCE; LYMPHOCYTE PROLIFERATION; MALE; MONITORING; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; VIRUS IMMUNITY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; DNA, VIRAL; FEMALE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, CELLULAR; INFANT; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 79952621925     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.09.010     Document Type: Article

References (44)

1. Wigger H.J., Blanc W.A. Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia. N Engl J Med 1966, 275:870-874.
2. Wensley D.F., Baldwin V.J. Respiratory distress in the second week of life. J Pediatr 1985, 106:326-331.
3. Abzug M.J., Levin M.J. Neonatal adenovirus infection: four patients and review of the literature. Pediatrics 1991, 87:890-896.
4. Kojaoghlanian T., Flomenberg P., Horwitz M.S. The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 2003, 13:155-171.
5. Echavarria M., Forman M., van Tol M.J., Vossen J.M., Charache P., Kroes A.C. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 2001, 358:384-385.
6. van Tol M.J., Claas E.C., Heemskerk B., et al. Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity. Bone Marrow Transplant 2005, 35(Suppl 1):S73-S76.
7. Feuchtinger T., Lang P., Handgretinger R. Adenovirus infection after allogeneic stem cell transplantation. Leuk Lymphoma 2007, 48:244-255.
8. Lion T., Baumgartinger R., Watzinger F., et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003, 102:1114-1120.
9. Myers G.D., Krance R.A., Weiss H., et al. Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant 2005, 36:1001-1008.
10. Schilham M.W., Claas E.C., van Zaane W., et al. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis 2002, 35:526-532.
11. Lenaerts L., Naesens L. Antiviral therapy for adenovirus infections. Antiviral Res 2006, 71:172-180.
12. Chakrabarti S., Mautner V., Osman H., et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002, 100:1619-1627.
13. Kampmann B., Cubitt D., Walls T., et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005, 130:595-603.
14. Avivi I., Chakrabarti S., Milligan D.W., et al. Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol Blood Marrow Transplant 2004, 10:186-194.
15. Leen A.M., Bollard C.M., Myers G.D., Rooney C.M. Adenoviral infections in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006, 12:243-251.
16. Heemskerk B., Lankester A.C., van Vreeswijk T., et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis 2005, 191:520-530.
17. Feuchtinger T., Lucke J., Hamprecht K., et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2005, 128:503-509.
18. Myers G.D., Bollard C.M., Wu M.F., et al. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 2007, 39:677-686.
19. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998, 393:480-483.
20. Shedlock D.J., Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003, 300:337-339.
21. Sun J.C., Bevan M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003, 300:339-342.
22. Klenerman P., Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol 2005, 6:873-879.
23. Lilleri D., Fornara C., Furione M., Zavattoni M., Revello M.G., Gerna G. Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J Infect Dis 2007, 195:1062-1070.
24. Lilleri D., Fornara C., Revello M.G., Gerna G. Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection. J Infect Dis 2008, 198:536-543.
25. Guerin V., Dalle J.H., Pedron B., et al. Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation. Bone Marrow Transplant 2010, 45:442-449.
26. Pourgheysari B., Piper K.P., McLarnon A., et al. Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT. Bone Marrow Transplant 2009, 43:853-861.
27. Walter E.A., Greenberg P.D., Gilbert M.J., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995, 333:1038-1044.
28. Boaz M.J., Waters A., Murad S., Easterbrook P.J., Vyakarnam A. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J Immunol 2002, 169:6376-6385.
29. Darrah P.A., Patel D.T., De Luca P.M., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007, 13:843-850.
30. Emu B., Sinclair E., Favre D., et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005, 79:14169-14178.
31. Harari A., Vallelian F., Meylan P.R., Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 2005, 174:1037-1045.
32. Millington K.A., Innes J.A., Hackforth S., et al. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007, 178:5217-5226.
33. Younes S.A., Yassine-Diab B., Dumont A.R., et al. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 2003, 198:1909-1922.
34. Feuchtinger T., Matthes-Martin S., Richard C., et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006, 134:64-76.
35. Leen A.M., Myers G.D., Sili U., et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med 2006, 12:1160-1166.
36. Flomenberg P., Piaskowski V., Truitt R.L., Casper J.T. Characterization of human proliferative T cell responses to adenovirus. J Infect Dis 1995, 171:1090-1096.
37. Souberbielle B.E., Russell W.C. Human T cell proliferative response to polypeptides from adenovirus type 2. J Infect Dis 1995, 172:1421-1422.
38. Heim A., Ebnet C., Harste G., Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 2003, 70:228-239.
39. Veltrop-Duits L.A., Heemskerk B., Sombroek C.C., et al. Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus. Eur J Immunol 2006, 36:2410-2423.
40. Garnett C.T., Erdman D., Xu W., Gooding L.R. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 2002, 76:10608-10616.
41. Leung A.Y., Chan M., Cheng V.C., Yuen K.Y., Kwong Y.L. Quantification of adenovirus in the lower respiratory tract of patients without clinical adenovirus-related respiratory disease. Clin Infect Dis 2005, 40:1541-1544.
42. Neumann R., Genersch E., Eggers H.J. Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res 1987, 7:93-97.
43. Revello M.G., Lilleri D., Zavattoni M., et al. Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers. J Infect Dis 2006, 193:269-276.
44. de Pagter A.P., Haveman L.M., Schuurman R., Schutten M., Bierings M., Boelens J.J. Adenovirus DNA positivity in nasopharyngeal aspirate preceding hematopoietic stem cell transplantation: a very strong risk factor for adenovirus DNAemia in pediatric patients. Clin Infect Dis 2009, 49:1536-1539.